Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Navy SEALs depend on cutting-edge sensors, optics, and targeting gear to shape battles before they start. That relian...
Carvana’s pivot from pure online disruption to owning physical dealerships is surprising. This piece breaks down why ...
What could happen to NuScale Power stock over the next five years? This article breaks down the catalysts, scenarios,...
When Warren Buffett's successor Greg Abel took the helm, Berkshire Hathaway signaled a new phase. This article breaks...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
HIVE Digital Tech shares surged as analysts raised targets ahead of earnings, highlighting AI data centers' growing r...
Nuclear energy is back on the radar as a reliable, scalable power source. This guide explains how a $5,000 investment...
As AI startups eye the public markets, anthropic goes public trillion could unlock a new wave of investor opportuniti...
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
Taiwan Semiconductor is in the spotlight as it signals higher capital spending. This article breaks down whether tsmc...
A rally in AeroVironment shares has investors wondering what sparked the move. This guide breaks down the factors beh...